JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304809200 on May 14, 2003

J. Biol. Chem., Vol. 278, Issue 33, 30450-30457, August 15, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/30450    most recent
M304809200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakao, E.
Right arrow Articles by Takiguchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakao, E.
Right arrow Articles by Takiguchi, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Two-peaked Synchronization in Day/Night Expression Rhythms of the Fibrinogen Gene Cluster in the Mouse Liver*

Eiko Sakao {ddagger} §, Akinori Ishihara {ddagger}, Kazumasa Horikawa ¶, Masashi Akiyama ¶, Makoto Arai ||, Masaki Kato ||, Naohiko Seki ||, Kohji Fukunaga **, Atsuko Shimizu-Yabe {ddagger}, Katsuro Iwase {ddagger}, Satoko Ohtsuka {ddagger} §, Takeyuki Sato §, Yoichi Kohno §, Shigenobu Shibata ¶ and Masaki Takiguchi {ddagger} {ddagger}{ddagger}

From the {ddagger}Departments of Biochemistry and Genetics, §Pediatrics, and ||Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan, the Department of Pharmacology and Brain Science, School of Human Science, Waseda University, Tokorozawa 359-1192, Japan, and the **Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan

Received for publication, May 7, 2003


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Genes expressed with day/night rhythms in the mouse liver were searched for by microarray analysis using an in-house array harboring mouse liver cDNAs. The rhythmic expression with a single peak and trough level was confirmed by RNA blot analysis for 3{beta}-Hsd and Gabarapl1 genes exhibiting a peak in the light phase and Spot14, Hspa8, Hspa5, and Hsp84-1 genes showing a peak in the dark phase. On the other hand, mRNA levels for all of the three fibrinogen subunits, A{alpha}, B{beta} and {gamma}, exhibited two peaks each in the light and dark phases in a synchronized manner. This two-peaked rhythmic pattern of fibrinogen genes as well as the single peaktrough pattern of other genes was diminished or almost completely lost in the liver of Clock mutant mice, suggesting that the two-peaked expression is also under the control of oscillation-generating genes. In constant darkness, the first peak of the expression rhythm of fibrinogen genes was almost intact, but the second peak disappeared. Therefore, although the first peak in the subjective day is a component of the innate circadian rhythm, the second peak seems to require light stimuli. Fasting in constant darkness caused shifts of time phases of the circadian rhythms. Protein levels of the fibrinogen subunits in whole blood also exhibited circadian rhythms. In the mouse and human loci of the fibrinogen gene cluster, a number of sequence elements resembling circadian transcription factor-binding sites were found. The fibrinogen gene locus provides a unique system for the study of two-peaked day/night rhythms of gene expression in a synchronized form.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
In mammals, intracellular oscillation generators for circadian rhythms reside in various peripheral organs such as liver as well as in the central pacemaker, the suprachiasmatic nucleus (SCN)1 of the hypothalamus (1, 2). The SCN and peripheral tissues seem to share common molecular mechanisms for generating the circadian oscillation. The widely accepted mechanism is autoregulatory feedback inhibition of period (Per) and cryptochrome (Cry) genes by their own protein products in antagonism with the positive transcription factor of the CLOCK-BMAL1 heterodimer (38).

The time phase of the SCN oscillator is adjusted by light stimuli everyday in the light-dark condition (1, 2). The SCN then controls or affects the oscillators of peripheral cells in both relatively direct and indirect manners. The liver provides a well characterized example of these regulations. Although oscillation generators of liver cells are under the circadian control of glucocorticoids (9, 10), presumably through the hypothalamus-hypophysis-adrenal axis, time phases of the liver oscillators are more profoundly affected by feeding time (1113). Artificial diurnal feeding of nocturnal rodents can completely uncouple the oscillation phase of the liver from that of the SCN. Seemingly, the SCN regulates the liver oscillators indirectly by controlling the sleep-awakeness phase that in turn determines the feeding time under the natural condition.

Recently, hundreds of genes exhibiting circadian oscillation in their mRNA levels have been identified in the rodent liver (1419) by comprehensive gene expression analysis including the microarray analysis, showing that a number of liver functions are under the circadian control at the gene expression level. These genes seem to show mainly circadian rhythms with a single peak-trough a day, because most of the genes were identified by the algorithms examining the fitness to cosine wave patterns with ~24 h of cycles in constant darkness. Here, in the course of cDNA microarray analysis and following RNA blot analysis, we found by chance that mRNAs for all of the three fibrinogen subunits, A{alpha}, B{beta}, and {gamma}, exhibit peak levels twice a day under the light-dark condition in the mouse liver. Fibrinogen, a major component of blood coagulation, in the blood plasma has the subunit composition of (A{alpha})2(B{beta})2{gamma}2 from which N-terminal peptides A and B are proteolytically removed by thrombin, yielding fibrin with the {alpha}2{beta}2{gamma}2 composition (20). Apparently, corresponding with this stoichiometry of the subunit composition, the two-peaked rhythms of fibrinogen genes were synchronized. In constant darkness, the second peak of daily rhythms of fibrinogen genes disappeared, whereas the first peak was almost intact. In human (21) and rat (22), the three fibrinogen genes were shown to be clustered on chromosome 4 (4q31) and chromosome 2 (2q31–34), respectively, which is also the case for mouse chromosome 3 (3 E3-F1) as confirmed by the genome sequence (23). Candidate sequence elements for the rhythmic regulation were mapped in the mouse and human loci of the fibrinogen gene cluster.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Animals—Microarray analysis utilized 6-week-old male ddY mice (Takasugi Bioanimal, Saitama, Japan). Clock mutant C57BL/6J mice for analysis of rhythmicity were purchased from Jackson Laboratory (stock number 002923, Bar Harbor, ME) and interbred in Waseda University. Genotypes were determined by PCR as described previously (4). Mice were maintained on a light-dark cycle (12-h light, 12-h dark) at a room temperature of 23 °C and given food and water ad libitum. Lights-on time was assigned Zeitgeber time (ZT) 0, and then lights-off time was assigned ZT12. For experiments in constant darkness, C57BL/6N mice purchased from Charles River Japan Inc. (Yokohama, Japan) were housed under the light-dark condition for 2 weeks before transferring to constant darkness

cDNA Microarray Analysis—A microarray was prepared essentially as described previously (24) with 2,304 mouse liver cDNA clones provided by K. Hashimoto (National Institute of Infectious Diseases, Tokyo, Japan) and S. Sugano (Institute of Medical Sciences, University of Tokyo, Tokyo, Japan). Total liver RNA was prepared from ddY mice at ZT6 and 18 by the acid-guanidine thiocyanate-phenol/chloroform extraction procedure (25) and subjected to poly(A)+ RNA isolation using oligo(dT)-paramagnetic beads Dynabeads Oligo(dT)25 (Dynal, Oslo, Norway). 2 µg of poly(A)+ RNA and 4.5 µg of oligo(dT) in 15 µl of solution were heat-denatured at 70 °C for 10 min and immediately chilled on ice. The mixture was made up to 30 µl of the solution containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 0.5 mM each of dATP, dCTP, and dGTP, 0.2 mM dTTP, 0.1 mM Cy3- or Cy5-dUTP, and 400 units of reverse transcriptase SuperScript II (Invitrogen). The reaction was allowed to proceed at 42 °C for 1 h. After alkaline degradation of template RNA, the Cy3- or Cy5-labeled cDNA was purified with Centricon-30 microconcentrators (Millipore, Bedford, MA). Hybridization was carried out in a solution containing 2 µg/µl yeast RNA, 2 µg/µl poly(A), 3.4x SSC (1x SSC consists of 0.15 M NaCl and 15 mM sodium citrate), and 0.3% SDS at 65 °C overnight under humidified condition. Washing was done twice for 5 min with 2x SSC, 0.1% SDS at room temperature and twice for 5 min with 0.2x SSC, 0.1% SDS at 40 °C followed by rinse with 0.2x SSC. The fluorescent images were scanned with a laser-scanning device (Scan-Array4000, GSI Lumonics, Bedford, MA).

Northern Blot Analysis—Total liver RNA and sense strand cRNA amplified from poly(A)+ RNA were subjected to Northern analysis. The detailed procedure for cRNA amplification will be described elsewhere. Double-stranded cDNA synthesized from poly(A)+ RNA absorbed on the oligo(dT) beads was ligated with the T7 promoter adaptor and heat-denatured, liberating the sense strand cDNA, which was again converted to double-stranded form priming from the oligo(dT) linker, amplified with PCR using as primers known sequences of both ends, and then subjected to synthesis of sense strand cRNA with T7 RNA polymerase. RNAs were electrophoresed in denaturing formaldehyde-agarose (1%) gels, visualized by ethidium bromide staining to check integrity and equal loading, and then blotted onto nylon membranes. Digoxigenin-labeled RNA probes were synthesized using a transcription kit (Roche Diagnostics) from cDNAs subcloned in the plasmid pGEM-3Zf(+). Hybridization, washing, and chemiluminescent detection on x-ray films were done as recommended by Roche Diagnostics. Densitometric quantification was performed by using Personal Scanning Image (PDSI, Molecular Dynamics, Sunnyvale, CA).

Western Blot Analysis—Whole blood was collected from the inferior vena cava of mice with heparinized syringes and tubes, and subjected to immunodetection of fibrinogen subunits essentially as described previously (26). The blood was serially diluted with 19 and 5.25 volumes of 70 mM Tris-HCl buffer (pH 6.8) containing 3% SDS, 5% 2-mercaptoethanol, 11.2% glycerol, and 0.02% bromphenol blue. The diluted samples containing 0.08 µl of whole blood in 20 µl of solution were subjected to SDS-PAGE with 10% acrylamide gel, and proteins were electrotransferred to nitrocellulose membranes. Immunodetection was performed using a goat IgG against mouse fibrinogen (1:1,000 dilution, Nordic Immunological Laboratories, Tilburg, The Netherlands) as a primary antibody, a peroxidase-conjugated rabbit IgG F(ab')2 against the goat IgG (1:5,000 dilution, Wako Pure Chemical Industries, Osaka, Japan) as a secondary antibody and ImmunoStar Reagents (Wako, Japan) for chemiluminescence detection. Signals detected on x-ray films were densitometrically quantified.

Data Base Search—cDNA sequences deposited in IMAGE were accessed through Search GenBankTM-Today Data Base using DBGET (www.genome.ad.jp/dbget-bin/www_bfind?genbank-today), queried in NCBI BLAST (www.ncbi.nlm.nih.gov:80/BLAST/), and assigned to specific genes with NCBI UniGene (www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene) and NCBI LocusLink (www.ncbi.nlm.nih.gov/LocusLink/). Mouse and human genome sequences were from Mouse Genome Server (www.ensembl.org/Mus_musculus/) and Human Genome Server (www.ensembl.org/Homo_sapiens/), respectively, in Ensembl (www.ensembl.org/).


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
cDNA Microarray Analysis of Day/Night Gene Expression in the Mouse Liver—Microarray analysis was carried out to detect differentially expressed genes between light (ZT6) and dark (ZT18) phases. We used an in-house microarray (24) containing ~2,300 mouse liver cDNA clones. Poly(A)+ RNAs derived from the liver at ZT6 and ZT18 in duplicate were subjected to Cy3 and Cy5 labeling, respectively, coupled with cDNA synthesis. Both labeled cDNAs were mixed in an equal amount and hybridized with a microarray. Labeling vice versa with Cy3 and Cy5 was also done to correct a possible difference in incorporation efficiency of these dyes. Tables I and II represent lists for genes that showed the higher mRNA levels at ZT6 and ZT18, respectively, at least 1.5-fold in all four experiments of the microarray analysis. Remarkably, genes for all of the three fibrinogen subunits, A{alpha}, B{beta} and {gamma}, showed the higher expression at ZT6 (Table I). It is also noteworthy that a number of genes possibly involved in gene expression ranging from transcription to protein transport showed the higher expression at ZT18 (Table I). Spot14 is a putative transcriptional regulator (27, 28), and leucine zipper protein 1 is a basic protein localized in the nucleus (29). Heat shock 70-kDa protein 8 (Hspa8), heat shock 70-kDa protein 5 (Hspa5) (78-kDa glucose-regulated protein), and heat shock protein 84-kDa 1 (Hsp84-1) are molecular chaperones (30), and peroxisome biogenesis factor 7 is involved in posttranslational protein transport into the organelle (31, 32). Seemingly, these genes are involved in synthesis and delivery of proteins in a dark phase-specific manner.


View this table:
[in this window]
[in a new window]
 
TABLE I
Genes exhibiting the higher expression in the light phase (ZT6)

 

View this table:
[in this window]
[in a new window]
 
TABLE II
Genes exhibiting the higher expression in the dark phase (ZT18)

 

To confirm the validity of the microarray analysis, we performed Northern analysis for six genes, i.e. two and four genes that showed the higher expression at ZT6 and ZT18, respectively, more than 2-fold in all four experiments. Total liver RNAs at ZT6 and ZT18 in duplicate were subjected to the blot analysis (Fig. 1A). Concordant with the results of the microarray analysis, mRNA levels for 3{beta}-hydroxy-{Delta}5-C27-steroid oxidoreductase (3{beta}-HSD) (33) and GABA(A) receptor-associated protein-like 1 (Gabarapl1) (34) were higher at ZT6 than ZT18 and those for Spot14, Hspa8, Hspa5, and Hsp84-1 were higher at ZT18 than ZT6. We also performed Northern analysis by using poly(A)+ RNA-derived sense strand cRNA (Fig. 1B) to exclude the possibility that the results obtained with total RNA may reflect daily fluctuation of poly(A)+ RNA contents in total RNA. Again, changes in the gene expression levels detected with the cRNA mixtures were concordant with the results of the microarray analysis for both gene groups each exhibiting the higher expression at ZT6 or ZT18. We concluded that our microarray system successfully revealed genes differentially expressed between light and dark phases.



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 1.
Northern blot analysis for changes in mRNA levels in the mouse liver between the light phase (ZT6) and dark phase (ZT18). Total RNAs (A) and sense strand cRNAs amplified from poly(A)+ RNAs (B) in duplicate were subjected to Northern analysis for indicated mRNAs. 2 µg of total RNA and 0.5 µg of cRNA/lane were electrophoresed. The arrows show bands of marked mRNAs. The bars represent positions of 28 S and 18 S rRNAs.

 

Genes Exhibiting Rhythmic Expression with a Single Peak-Trough—Rhythmic patterns of expression of the six genes were examined by Northern analysis with total RNA extracted from the liver of wild-type mice at 4-h intervals in a light-dark cycle. In parallel, we also investigated the mice with Clock mutation that yields a splice variant of a dominant-negative type (35) to see whether the rhythmic expression of the six genes are under the control of oscillation-generating genes. As shown in Fig. 2A, mRNA levels for 3{beta}-HSD and Gabarapl1 in the wild-type mice exhibited day/night rhythm with a peak in the light phase and a trough in the dark phase. In the Clock mutant mice, the rhythmic oscillations of these genes were apparently attenuated, indicating that CLOCK plays a role in the regulation of 3{beta}-Hsd and Gabarapl1 genes.



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 2.
Northern analysis for day/night expression rhythms of genes with the higher mRNA levels in the light phase (A) and the dark phase (B). Total RNA was prepared from the liver of wild-type and Clock mutant (mutation-homozygous) mice at 4-h intervals in the Zeitgeber time of the light-dark cycle (shown by open and solid bars) and subjected to Northern analysis for indicated mRNAs. Below the representative chemiluminogram, quantified results are shown. mRNA levels relative to the maximum value (100%) for three independent experiments are represented by mean ± S.E.

 

Fig. 2B shows the results of similar analysis on Spot14, Hspa8, Hspa5, and Hsp84-1 genes with the higher expression in the dark phase. In the wild-type mice, each mRNA level for these genes showed a peak in the dark phase and a trough in the light phase. On the other hand, the rhythmic oscillations of the four genes were attenuated or almost completely lost in Clock mutant mice. Taken together with the results of Fig. 2A, both gene groups, each displaying a peak expression in the light or dark phase, seem to be under the control of the Clock gene.

Two-peaked Day/Night Rhythms in Expression of Fibrinogen Genes—We also examined daily changes in expression of genes for fibrinogen subunits by Northern analysis (Fig. 3). Interestingly, in wild-type mice, mRNA levels for all three fibrinogen subunits, A{alpha}, B{beta}, and {gamma}, peaked twice at ZT7 and 19 in a day. The time phase and oscillation amplitude of the two-peaked rhythm were synchronized among the three genes. Since fibrinogen protein in the blood plasma consists of three pairs of each subunit leading to the composition (A{alpha})2(B{beta})2{gamma}2 (20), synchronization in expression of the subunit genes is suited for maintenance of this stoichiometry. In Clock mutant mice, the rhythmicity appeared to be shifted to the weak single peak-trough pattern for the A{alpha} gene or almost completely lost for the B{beta} and {gamma} genes. Therefore, the two-peaked expression of fibrinogen genes is also likely to be under the control of the Clock gene.



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 3.
Two-peaked synchronization in day/night expression rhythms of the fibrinogen genes. Northern analysis for mRNAs of three fibrinogen subunits A{alpha} (Fga), B{beta} (Fgb), and {gamma} (Fgg) were carried out as described in the legend of Fig. 2.

 

To examine effects of the light-dark cycle and food intake on the daily rhythms of expression of fibrinogen genes, mice were kept in constant darkness and half of them were fasted (Fig. 4). Mice transferred to constant darkness on day 1 were subjected to liver excision at 4-h intervals from circadian time (CT) 3 to CT23 on day 2 (Fig. 4A). In Northern analysis for the fibrinogen subunit mRNAs (Fig. 4B, left panels), the second peak observed in the nighttime under the light-dark condition was not detected in the subjective night under constant darkness. On the other hand, the first peak was almost intact with some prolongation of the peak phase. Therefore, while the first peak in the subjective day is caused mainly by the innate circadian mechanism, the second peak seems to be generated by light stimuli (i.e. lights-on, continuous irradiation, and/or lights-off) most probably by lights-off at least as a component that affects the time phase of the second peak.



View larger version (35K):
[in this window]
[in a new window]
 
FIG. 4.
Circadian rhythms of mRNA and protein levels of fibrinogen subunits in constant darkness, and effects of fasting. A, experimental schedule. Mice were housed under the light-dark condition (represented by open and solid bars) for 2 weeks until day 0 and transferred to constant darkness (Dark/Dark) on day 1. The subjective day is represented by the hatched box. Livers and whole blood were collected at 4-h intervals of CT indicated by vertical arrows on day 2. When fasted, mice were food-depleted at CT11 of day 1. B, Northern analysis. Total RNA was prepared from the liver of mice fed ad libitum or fasted at indicated CT points (each three mice) and subjected to Northern analysis for mRNAs of three fibrinogen subunits A{alpha} (Fga), B{beta} (Fgb), and {gamma} (Fgg). Below the chemiluminogram, quantified results are shown. mRNA levels relative to the maximum value (100%) for each subunit are represented by mean ± S.E. C, Western analysis. Samples containing 0.08 µl of whole blood were subjected to immunodetection of fibrinogen subunits with an anti-fibrinogen antibody. Below the representative chemiluminogram, quantified results are shown. Protein levels relative to the maximum value (100%) for each subunit in three independent experiments are represented by mean ± S.E.

 

Effects of food depletion were also examined, because it is well known that feeding time profoundly affects the time phases of the liver oscillators (1113). Foods were depleted at CT11 on day 1 just before beginning of the feeding period of nocturnal mice in the subjective night (Fig. 4A). Fasting caused shifts of time phases in the expression rhythms of fibrinogen subunit genes (Fig. 4B, right panels). Directions of the shifts remain to be determined experimentally, but we assume that forward shifts took place because fasting brings about forward shifts of the rhythms of mPer1 and mPer2 mRNA levels in the liver.2 Synchronization of the time phase among the subunit mRNAs seemed to be loosened by the fasting, the reason being remains to be clarified.

Rhythms of protein levels for the fibrinogen subunits in constant darkness were examined by Western analysis with whole blood (Fig. 4C). When mice were fed ad libitum (left panels), the three subunits exhibited synchronized circadian rhythms with an apparent peak at CT7 and possibly a low peak at CT15. Compared with the mRNA rhythms (Fig. 4B, left panels), this is rather an unexpected result. Direct reflection of mRNA levels to protein levels would have resulted in mimicking mRNA patterns by protein patterns with the lag time of several hours. Seemingly, circadian rhythms of fibrinogen protein levels are controlled not only by mRNA levels but also by other mechanisms such as regulations in the steps of translation, secretion, and protein degradation. Again, fasting appeared to cause shifts of time phases of fibrinogen protein rhythms, although individual variations of protein levels were relatively large under the fasting.

In human, it was demonstrated that plasma fibrinogen concentrations exhibit a day/night rhythm (3638). Whereas the rhythm has been approximated by the cosine curve with a single peak in the early morning (38), reconsideration of the original data of Kanabrocki et al. (38) suggests the presence of the second peak or a shoulder in the evening. Therefore, human fibrinogen seems to be set to increase rapidly in the morning and persist around the daytime, i.e. a physically active period in human. The peak in the early morning has been implicated in the incidence of arterial ischemic diseases such as myocardial infarction (38).

Putative Regulatory Elements for Rhythmic Expression of the Fibrinogen Gene Cluster—The two-peaked rhythmicity suggests that at least two or possibly more transcription factors are involved in daily regulation of the fibrinogen subunit genes. On the other hand, synchronization in expression of subunit genes implies that they share common regulatory mechanisms. We searched for putative cis-regulatory elements interacting with circadian transcription factors in the fibrinogen gene cluster (Fig. 5). Recent determination of the mouse genome sequence (23) confirmed the presence of the fibrinogen gene cluster, which was predictable from the cytogenetic map (Table I) and from previous reports on homologous clusters of human (21) and rat (22). The searched sequences were as follows: the E-box element CACGTG that is recognized by CLOCK/BMAL1 (3, 39) and NPAS2/BMAL1 (40) and that is also the target of repressors such as PER/CRY (5, 8) and recently characterized Dec1 and Dec2 (41); the REV-ERB{alpha} site WAWNTRGGTCA (W = A or T, R = A or G) that is recognized by members of nuclear orphan receptor REV-ERB and retinoic acid-related orphan receptor families and that is responsible for circadian regulation (19) by REV-ERB{alpha} as a well characterized member (42); the DBP site RTTAYGTAAY (R = AorG, Y = C or T) that is the binding sequence of circadian transcription factors DBP, thyrotroph embryonic factor, and hepatocyte leukemia factor of the PAR-ZIP (proline- and acidic amino acid-rich region-leucine zipper) family (43) and its variant E4BP4 (44); and the glucocorticoid response element (GRE) GGTACANNNTGTTCT (45) that is the recognition sequence of the nuclear receptor bound and activated by glucocorticoids, a major humoral regulator of the liver clock (9, 10). Completely matched sequences for the E-box and one mismatch-allowed sequence for the other sites are marked on mouse (Fig. 5A) and human (Fig. 5B) fibrinogen gene cluster loci with 10-kb flanking regions.



View larger version (55K):
[in this window]
[in a new window]
 
FIG. 5.
Distribution of candidates for binding sites of circadian transcription factors in the fibrinogen gene cluster of mouse (A) and human (B). Nucleotide sequences of mouse (A) and human (B) fibrinogen gene clusters with 10-kb 5'-and 3'-flanking regions were derived from the Ensembl data base. The top bar indicates the scale for chromosome positions. The second bar represents locations of genes for fibrinogen subunits A{alpha} (Fga), B{beta} (Fgb), and {gamma} (Fgg). Exons are shown by nodes. The sense strand of Fgb is on the opposite DNA strand of Fga and Fgg. Nucleotide positions of 5' and 3' ends of each gene are shown above the scale indicated by the third bar (the position 10-kb upstream from the 5' end of Fgg is designated as 1). The bottom bar shows locations of candidate sequences for circadian transcription factor-binding sites. Perfect-matched sequences for the E-box element CACGTG and one mismatch-allowed sequence for the REV-ERB{alpha} site WAWNTRGGTCA (W = A or T, R = A or G), the DBP site RTTAYGTAAY (R = A or G, Y = C or T), and the GRE GGTACANNNTGTTCT are listed. The mismatched nucleotides are indicated by lowercase letters. Symbols + and – denote that the displayed sequences are found on the upper and lower DNA strands, respectively.

 

A number of candidate sequences for each site were found. Exceptionally, only one GRE-like sequence was detected in both mouse and human, and its location is relatively similar between the two species, i.e. around the 3'-terminal region of the fibrinogen B{beta} gene. Therefore, this putative GRE may be functional and conservatory. Previous studies have proposed the presence of GREs for rat A{alpha} and B{beta} genes but have not identified them (46). In the 5'-flanking region of the {gamma} gene, sequences each resembling the E-box, REV-ERB{alpha} site, or DBP site seem to be arranged similarly between mouse and human and may play regulatory roles common to both species. On the other hand, frequencies of the three elements in the whole locus are rather different between the two species and each frequency in the mouse versus human locus is as follows (the number within parentheses shows the frequency of completely matched sequences): the E-box 9 (9) versus 3 (3); the REV-ERB{alpha} site 25 (4) versus 41 (2); and the DBP site 16 (0) versus 44 (2). It is tempting to speculate that relatively high frequencies of the E-box in mouse and the REV-ERB{alpha} and DBP sites in human are implicated in species-specific regulations in mouse and human adapted to nocturnal and diurnal activity, respectively. It will be extremely interesting to investigate the roles of these putative cis-elements in two-peaked synchronization in the expression of the fibrinogen gene cluster that is under the control of both innate circadian mechanism and seemingly light-responsive mechanism.


    FOOTNOTES
 
* This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Science, Sports and Technology of Japan, the Hamaguchi Foundation for the Advancement of Biochemistry, and the Yamada Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Biochemistry and Genetics, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chiba 260-8670, Japan. Tel.: 81-43-226-2035; Fax: 81-43-226-2037; E-mail: mtak{at}med.m.chiba-u.ac.jp.

1 The abbreviations used are: SCN, suprachiasmatic nucleus; ZT, Zeitgeber time; Hspa, heat shock 70-kDa protein; 3{beta}-HSD, 3{beta}-hydroxy-{Delta}5-C27-steroid oxidoreductase (dehydrogenase); Gabarapl1, GABA(A) receptor-associated protein-like 1; Hsp84-1, heat shock protein 84-kDa 1; Fg, fibrinogen; CT, circadian time; GRE, glucocorticoid response element; REV/ERB{alpha}, reverse strand gene of erbA{alpha}; DBP, albumin site D-binding protein. Back

2 K. Horikawa, Y. Minami, M. Iijima, R. Aida, M. Akiyama, and S. Shibata, manuscript in preparation. Back


    ACKNOWLEDGMENTS
 
We are grateful to K. Hashimoto and S. Sugano for providing us cDNA clones for the microarray. We also thank T. Hiwasa and our colleagues for suggestions, help, and discussions.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Ripperger, J. A., and Schibler, U. (2001) Curr. Opin. Cell Biol. 13, 357–362[CrossRef][Medline] [Order article via Infotrieve]
  2. Reppert, S. M., and Weaver, D. R. (2002) Nature 418, 935–941[CrossRef][Medline] [Order article via Infotrieve]
  3. Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., Takahashi, J. S., and Weitz, C. J. (1998) Science 280, 1564–1569[Abstract/Free Full Text]
  4. Jin, X., Shearman, L. P., Weaver, D. R., Zylka, M. J., de Vries, G. J., and Reppert, S. M. (1999) Cell 96, 57–68[CrossRef][Medline] [Order article via Infotrieve]
  5. Kume, K., Zylka, M. J., Sriram, S., Shearman, L. P., Weaver, D. R., Jin, X., Maywood, E. S., Hastings, M. H., and Reppert, S. M. (1999) Cell 98, 193–205[CrossRef][Medline] [Order article via Infotrieve]
  6. van der Horst, G. T., Muijtjens, M., Kobayashi, K., Takano, R., Kanno, S., Takao, M., de Wit, J., Verkerk, A., Eker, A. P., van Leenen, D., Buijs, R., Bootsma, D., Hoeijmakers, J. H., and Yasui, A. (1999) Nature 398, 627–630[CrossRef][Medline] [Order article via Infotrieve]
  7. Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin, C., Radcliffe, L. A., Hogenesch, J. B., Simon, M. C., Takahashi, J. S., and Bradfield, C. A. (2000) Cell 103, 1009–1017[CrossRef][Medline] [Order article via Infotrieve]
  8. Shearman, L. P., Sriram, S., Weaver, D. R., Maywood, E. S., Chaves, I., Zheng, B., Kume, K., Lee, C. C., van der Horst, G. T., Hastings, M. H., and Reppert, S. M. (2000) Science 288, 1013–1019[Abstract/Free Full Text]
  9. Balsalobre, A., Brown, S. A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H. M., Schütz, G., and Schibler, U. (2000) Science 289, 2344–2347[Abstract/Free Full Text]
  10. Le Minh, N., Damiola, F., Tronche, F., Schütz, G., and Schibler, U. (2001) EMBO J. 20, 7128–7136[CrossRef][Medline] [Order article via Infotrieve]
  11. Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., and Schibler, U. (2000) Genes Dev. 14, 2950–2961[Abstract/Free Full Text]
  12. Hara, R., Wan, K., Wakamatsu, H., Aida, R., Moriya, T., Akiyama, M., and Shibata, S. (2001) Genes Cells 6, 269–278[Abstract]
  13. Stokkan, K. A., Yamazaki, S., Tei, H., Sakaki, Y., and Menaker, M. (2001) Science 291, 490–493[Abstract/Free Full Text]
  14. Kornmann, B., Preitner, N., Rifat, D., Fleury-Olela, F., and Schibler, U. (2001) Nucleic Acids Res. 29, e51[Abstract/Free Full Text]
  15. Akhtar, R. A., Reddy, A. B., Maywood, E. S., Clayton, J. D., King, V. M., Smith, A. G., Gant, T. W., Hastings, M. H., and Kyriacou, C. P. (2002) Curr. Biol. 12, 540–550[CrossRef][Medline] [Order article via Infotrieve]
  16. Kita, Y., Shiozawa, M., Jin, W., Majewski, R. R., Besharse, J. C., Greene, A. S., and Jacob, H. J. (2002) Pharmacogenetics 12, 55–65[CrossRef][Medline] [Order article via Infotrieve]
  17. Panda, S., Antoch, M. P., Miller, B. H., Su, A. I., Schook, A. B., Straume, M., Schultz, P. G., Kay, S. A., Takahashi, J. S., and Hogenesch, J. B. (2002) Cell 109, 307–320[CrossRef][Medline] [Order article via Infotrieve]
  18. Storch, K. F., Lipan, O., Leykin, I., Viswanathan, N., Davis, F. C., Wong, W. H., and Weitz, C. J. (2002) Nature 417, 78–83[CrossRef][Medline] [Order article via Infotrieve]
  19. Ueda, H. R., Chen, W., Adachi, A., Wakamatsu, H., Hayashi, S., Takasugi, T., Nagano, M., Nakahama, K., Suzuki, Y., Sugano, S., Iino, M., Shigeyoshi, Y., and Hashimoto, S. (2002) Nature 418, 534–539[CrossRef][Medline] [Order article via Infotrieve]
  20. Mosesson, M. W., Siebenlist, K. R., and Meh, D. A. (2001) Ann. N. Y. Acad. Sci. 936, 11–30[Abstract/Free Full Text]
  21. Kant, J. A., Fornace, A. J., Jr., Saxe, D., Simon, M. I., McBride, O. W., and Crabtree, G. R. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 2344–2348[Abstract/Free Full Text]
  22. Marino, M. W., Fuller, G. M., and Elder, F. F. (1986) Cytogenet. Cell Genet. 42, 36–41[Medline] [Order article via Infotrieve]
  23. Mouse Genome Sequencing Consortium (2002) Nature 420, 520–562[CrossRef][Medline] [Order article via Infotrieve]
  24. Yoshikawa, T., Nagasugi, Y., Azuma, T., Kato, M., Sugano, S., Hashimoto, K., Masuho, Y., Muramatsu, M., and Seki, N. (2000) Biochem. Biophys. Res. Commun. 275, 532–537[CrossRef][Medline] [Order article via Infotrieve]
  25. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156–159[Medline] [Order article via Infotrieve]
  26. Heckel, J. L., Sandgren, E. P., Degen, J. L., Palmiter, R. D., and Brinster, R. L. (1990) Cell 62, 447–456[CrossRef][Medline] [Order article via Infotrieve]
  27. Brown, S. B., Maloney, M., and Kinlaw, W. B. (1997) J. Biol. Chem. 272, 2163–2166[Abstract/Free Full Text]
  28. Compe, E., De Sousa, G., François, K., Roche, R., Rahmani, R., Torresani, J., Raymondjean, M., and Planells, R. (2001) Biochem. J. 358, 175–183[CrossRef][Medline] [Order article via Infotrieve]
  29. Sun, D. S., Chang, A. C., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., and Chang, N. C. (1996) Genomics 36, 54–62[CrossRef][Medline] [Order article via Infotrieve]
  30. Frydman, J. (2001) Annu. Rev. Biochem. 70, 603–647[CrossRef][Medline] [Order article via Infotrieve]
  31. Distel, B., Erdmann, R., Gould, S. J., Blobel, G., Crane, D. I., Cregg, J. M., Dodt, G., Fujiki, Y., Goodman, J. M., Just, W. W., Kiel, J. A., Kunau, W. H., Lazarow, P. B., Mannaerts, G. P., Moser, H. W., Osumi, T., Rachubinski, R. A., Roscher, A., Subramani, S., Tabak, H. F., Tsukamoto, T., Valle, D., van der Klei, I., van Veldhoven, P. P., and Veenhuis, M. (1996) J. Cell Biol. 135, 1–3[Free Full Text]
  32. Braverman, N., Steel, G., Lin, P., Moser, A., Moser, H., and Valle, D. (2000) Genomics 63, 181–192[CrossRef][Medline] [Order article via Infotrieve]
  33. Schwarz, M., Wright, A. C., Davis, D. L., Nazer, H., Bjorkhem, I., and Russell, D. W. (2000) J. Clin. Invest. 106, 1175–1184[Medline] [Order article via Infotrieve]
  34. Xin, Y., Yu, L., Chen, Z., Zheng, L., Fu, Q., Jiang, J., Zhang, P., Gong, R., and Zhao, S. (2001) Genomics 74, 408–413[CrossRef][Medline] [Order article via Infotrieve]
  35. King, D. P., Zhao, Y., Sangoram, A. M., Wilsbacher, L. D., Tanaka, M., Antoch, M. P., Steeves, T. D., Vitaterna, M. H., Kornhauser, J. M., Lowrey, P. L., Turek, F. W., and Takahashi, J. S. (1997) Cell 89, 641–653[CrossRef][Medline] [Order article via Infotrieve]
  36. Petralito, A., Mangiafico, R. A., Gibiino, S., Cuffari, M. A., Miano, M. F., and Fiore, C. E. (1982) Chronobiologia 9, 195–201[Medline] [Order article via Infotrieve]
  37. Haus, E., Cusulos, M., Sackett-Lundeen, L., and Swoyer, J. (1990) Chronobiol. Int. 7, 203–216[Medline] [Order article via Infotrieve]
  38. Kanabrocki, E. L., Sothern, R. B., Messmore, H. L., Roitman-Johnson, B., McCormick, J. B., Dawson, S., Bremner, F. W., Third, J. L., Nemchausky, B. A., Shirazi, P., and Scheving, L. E. (1999) Clin. Appl. Thromb. Hemost. 5, 37–42[Abstract/Free Full Text]
  39. Darlington, T. K., Wager-Smith, K., Ceriani, M. F., Staknis, D., Gekakis, N., Steeves, T. D., Weitz, C. J., Takahashi, J. S., and Kay, S. A. (1998) Science 280, 1599–1603[Abstract/Free Full Text]
  40. Rutter, J., Reick, M., Wu, L. C., and McKnight, S. L. (2001) Science 293, 510–514[Abstract/Free Full Text]
  41. Honma, S., Kawamoto, T., Takagi, Y., Fujimoto, K., Sato, F., Noshiro, M., Kato, Y., and Honma, K. (2002) Nature 419, 841–844[CrossRef][Medline] [Order article via Infotrieve]
  42. Preitner, N., Damiola, F., Luis-Lopez-Molina, Zakany, J., Duboule, D., Albrecht, U., and Schibler, U. (2002) Cell 110, 251–260[CrossRef][Medline] [Order article via Infotrieve]
  43. Fonjallaz, P., Ossipow, V., Wanner, G., and Schibler, U. (1996) EMBO J. 15, 351–362[Medline] [Order article via Infotrieve]
  44. Mitsui, S., Yamaguchi, S., Matsuo, T., Ishida, Y., and Okamura, H. (2001) Genes Dev. 15, 995–1006[Abstract/Free Full Text]
  45. Evans, R. M. (1988) Science 240, 889–895[Abstract/Free Full Text]
  46. Fuller, G. M., and Zhang, Z. (2001) Ann. N. Y. Acad. Sci. 936, 469–479[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Biol RhythmsHome page
A. Ishihara, E. Matsumoto, K. Horikawa, T. Kudo, E. Sakao, A. Nemoto, K. Iwase, H. Sugiyama, Y. Tamura, S. Shibata, et al.
Multifactorial Regulation of Daily Rhythms in Expression of the Metabolically Responsive Gene Spot14 in the Mouse Liver
J Biol Rhythms, August 1, 2007; 22(4): 324 - 334.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. F. Reilly, E. J. Westgate, and G. A. FitzGerald
Peripheral Circadian Clocks in the Vasculature
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1694 - 1705.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
C. Bertolucci, M. Pinotti, I. Colognesi, A. Foa, F. Bernardi, and F. Portaluppi
Circadian Rhythms in Mouse Blood Coagulation
J Biol Rhythms, June 1, 2005; 20(3): 219 - 224.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Pinotti, C. Bertolucci, F. Portaluppi, I. Colognesi, E. Frigato, A. Foa, and F. Bernardi
Daily and Circadian Rhythms of Tissue Factor Pathway Inhibitor and Factor VII Activity
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 646 - 649.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/30450    most recent
M304809200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakao, E.
Right arrow Articles by Takiguchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakao, E.
Right arrow Articles by Takiguchi, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS